MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
53.10
-0.02 (-0.04%)
At close: Nov 17, 2026, 4:00 PM EST
53.37
+0.27 (0.51%)
After-hours: Nov 17, 2026, 4:15 PM EST
MBX Biosciences Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, MBX Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $95.09. The average 1-year stock price forecast is 79.08% higher than the current stock price, while the lowest is $80 (+50.66%) and the highest is $150 (+182.49%).
Price Target: $95.09 (+79.08%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MBX Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 8 | 8 | 9 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 12 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $90 | Buy | Initiates | $90 | +69.49% | Nov 12, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $80 | Buy | Reiterates | $80 | +50.66% | Nov 11, 2026 |
| UBS | UBS | Buy Maintains $90 | Buy | Maintains | $90 | +69.49% | Nov 10, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $84 | Buy | Maintains | $84 | +58.19% | Nov 10, 2026 |
| Barclays | Barclays | Buy Maintains $88 | Buy | Maintains | $88 | +65.73% | Oct 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.48
from -2.38
EPS Next Year
-4.35
from -3.48
EPS and Forward PE are based on non-GAAP adjusted numbers.